DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Alexander T, Sarfert R, Klotsche J. et al.
The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus.
Ann Rheum Dis 2015;
74 (07) 1474-1478
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.